ENST00000423588.1:c.920A>G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The ENST00000423588.1(CACNA2D1):​c.920A>G​(p.Asn307Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000727 in 550,506 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/17 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N307I) has been classified as Benign.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000073 ( 0 hom. )

Consequence

CACNA2D1
ENST00000423588.1 missense

Scores

1
14

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.456

Publications

0 publications found
Variant links:
Genes affected
CACNA2D1 (HGNC:1399): (calcium voltage-gated channel auxiliary subunit alpha2delta 1) The preproprotein encoded by this gene is cleaved into multiple chains that comprise the alpha-2 and delta subunits of the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. Mutations in this gene can cause cardiac deficiencies, including Brugada syndrome and short QT syndrome. Alternate splicing results in multiple transcript variants, some of which may lack the delta subunit portion. [provided by RefSeq, Nov 2014]
CACNA2D1 Gene-Disease associations (from GenCC):
  • short QT syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: ClinGen, Orphanet
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • developmental and epileptic encephalopathy 110
    Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • Brugada syndrome
    Inheritance: Unknown, AD Classification: LIMITED, NO_KNOWN Submitted by: Genomics England PanelApp, Ambry Genetics
  • Brugada syndrome 1
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.07200423).

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000423588.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA2D1
NM_000722.4
MANE Select
c.879+9840A>G
intron
N/ANP_000713.2P54289-2
CACNA2D1
NM_001302890.2
c.920A>Gp.Asn307Ser
missense
Exon 11 of 11NP_001289819.1E7ERK3
CACNA2D1
NM_001366867.1
c.879+9840A>G
intron
N/ANP_001353796.1P54289-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA2D1
ENST00000423588.1
TSL:1
c.920A>Gp.Asn307Ser
missense
Exon 11 of 11ENSP00000405395.1E7ERK3
CACNA2D1
ENST00000356860.8
TSL:1 MANE Select
c.879+9840A>G
intron
N/AENSP00000349320.3P54289-2
CACNA2D1
ENST00000443883.2
TSL:5
c.879+9840A>G
intron
N/AENSP00000409374.2H0Y715

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000727
AC:
4
AN:
550506
Hom.:
0
Cov.:
0
AF XY:
0.0000101
AC XY:
3
AN XY:
298028
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
15806
American (AMR)
AF:
0.0000576
AC:
2
AN:
34716
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
20026
East Asian (EAS)
AF:
0.00
AC:
0
AN:
32094
South Asian (SAS)
AF:
0.00
AC:
0
AN:
62774
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
33562
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4074
European-Non Finnish (NFE)
AF:
0.00000316
AC:
1
AN:
316840
Other (OTH)
AF:
0.0000327
AC:
1
AN:
30614
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
0.18
DANN
Benign
0.80
DEOGEN2
Benign
0.019
T
Eigen
Benign
-0.79
Eigen_PC
Benign
-0.97
FATHMM_MKL
Benign
0.0078
N
LIST_S2
Benign
0.35
T
M_CAP
Benign
0.00075
T
MetaRNN
Benign
0.072
T
MetaSVM
Benign
-1.0
T
PhyloP100
-0.46
PROVEAN
Benign
-0.66
N
REVEL
Benign
0.022
Sift
Pathogenic
0.0
D
Vest4
0.074
MutPred
0.21
Gain of phosphorylation at N307 (P = 0.0042)
MVP
0.12
ClinPred
0.099
T
GERP RS
0.82
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79030053; hg19: chr7-81679904; API